Honoring extraordinary contributions to cardiovascular science

The Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences provides national and international recognition and support to those at the forefront of cardiovascular sciences.

The recipient will be a leader in cardiovascular sciences, a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care.

The Schottenstein Laureate will also receive an honorarium of $100,000 (US).

Established by a $2 million endowment from humanitarian philanthropists Jay and Jeanie Schottenstein, the prize is chartered to The Ohio State University Wexner Medical Center’s Heart and Vascular Center, and will be awarded biennially.

Nomination Criteria and Form

Eligibility

This prestigious prize provides national and international recognition to a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving healthcare; or who has successfully pursued innovative biomedical research with demonstrated translational benefits to patient care. Those honored will be practitioners and/or scientists whose accomplishments and contributions have taken place over a career of dedicated and focused scientific discovery. The prize is awarded biennially. All nominations must be received by January 31, 2015 at 11:59 p.m. Eastern Time.

Nomination Process

The nomination process is a two-step process. No nomination will be considered unless both steps have been completed. Deadline for all entries is January 31, 2015 at 11:59 p.m. Eastern Time.

Complete the required fields on the nomination form regarding the nominee and the nominator.

Send all required documentation via email to Tracy.Mchugh@osumc.edu. In the subject line enter the name of the nominee along with Schottenstein Prize Nomination Information. For example:
Subject: John Smith – Schottenstein Prize Nomination Information

These items must be sent for the nominee to be considered:

  • A letter from the nominator describing the primary reasons by which the nominee merits consideration for the prize. Relevant criteria might include scientific innovation, creativity, leadership, education, dedication and importance of the nominee’s work to the field of cardiovascular research. Consideration will also be given to the nominee’s role as mento of young researchers and/or clinicians.
  • Nominee’s curriculum vitae
  • A brief, one-page biography including other awards received by nominee
  • A list of 6-8 peer-reviewed journal references that support the nomination. Do not send reprints.
  • Two letters of reference from individuals outside of the nominating institution
  • Supporting letters from up to three additional colleagues familiar with the nominee’s work.

Hard copies may be mailed instead of emailing. However, items must be postmarked by January 31, 2015 to be considered. Late entries will not be accepted. Please mail any hard copy entries to the following:

Dr. Thomas Ryan, Director of the HVC-
c/o Tracy McHugh
ATTN: Schottenstein Prize Nomination Committee
Ohio State’s Heart and Vascular Center
452 W 10th Ave
Columbus OH 43210

Schottenstein Prize Nomination Form

Past Winners of the Schottenstein Prize

Garret Fitzgerald

Garret FitzGerald, MD

2013 Prize Laureate

Dr. Garret FitzGerald is the McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia, where he chairs the Department of Pharmacology and directs the Institute for Translational Medicine and Therapeutics.

Christine Seidman

Christine Siedman, MD

2011 Prize Laureate

Christine Siedman, MD is Professor, Departments of Medicine and Genetics at Harvard Medical School and Brigham and Women’s Hospital, where she is also the Thomas W. Smith Professor of Medicine.

Pascal Goldschmidt

Pascal Goldschmidt, MD

2009 Prize Laureate

Pascal Goldschmidt, MD, was the inaugural recipient of the Schottenstein Prize. He is the Senior Vice President for Medical Affairs and Dean at the University of Miami Miller School of Medicine, and also serves as Chief Executive Officer of the University of Miami Health System.

Schottenstein Prize in Cardiovascular Sciences

SchottensteinPrizeInCardiovascularScience

Eligibility and Award Details

This prestigious prize provides national and international recognition to a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care or who has successfully pursued innovative biomedical research with demonstrated translational benefits to patient care.

Those honored will be practitioners and/or scientists whose accomplishments and contributions have taken place over a career of dedicated and focused scientific discovery.

The prize is awarded biennially. Check back in the future for application information for the 2015 award.

Jay and Jeanie Schottensteins

Jay and Jeanie Schottenstein

Jay and Jeanie Schottenstein are passionate about Ohio State. Their children – Joseph, Jeffrey and Jonathan – have each attended, or are attending the university. Jeanie, herself, is a graduate.

The passion doesn’t stop there. Jay and Jeanie and Jay’s parents and siblings all have philanthropic ties to the University; the Jerome Schottenstein Center bears his late father's name. One might say the colors of scarlet and gray run deep in Jay’s and Jeanie’s veins.

It was natural then, for them to pledge $2 million to The Ohio State University Wexner Medical Center in 2008 to create the Jay and Jeanie Schottenstein Prize in Cardiovascular Science. The prize establishes an endowed fund to award up to $100,000 biennially to a physician or researcher who is an international leader in the field of cardiovascular sciences.

Because prizes of such magnitude are rare in scientific research and medicine, the Schottenstein Prize is expected to generate a lot of excitement.

"By providing this prize for cardiovascular sciences, we hope to further establish Ohio State as a leader in cardiovascular care and assure that it continues to set the bar for other institutions, nationally and internationally,” Jay says.

“This award will create a connection between Ohio State and some of the most outstanding cardiovascular scientists in the world,” adds Jeanie. “Our goal in establishing this prize is to make a strong institution even stronger.”

According to Ohio State’s Heart and Vascular Center Director, Thomas Ryan, MD, this prize will not only provide international recognition to someone who is on the leading edge of his or her field, it will also offer an unparalleled educational opportunity for OSU’s academic, medical and research communities and the community at large. The awarding of this prize will expose these groups to the knowledge and discoveries of a physician or researcher of great talent and caliber.

“Our vision at Ohio State’s Heart and Vascular Center is to leverage advanced techniques and technologies to innovate and translate knowledge into personalized heart care,” explains Ryan. “The Schottenstein Prize offers another avenue through which to accomplish this.”

“The creation of the Shottenstein Prize addresses two important goals. First, it greatly enhances the reputation of OSU on the international stage as an institution where world-class science is recognized and valued. Second, it will expose our students, trainees, and faculty to the luminaries in modern cardiovascular medicine. I am both grateful and proud that we have been afforded this wonderful opportunity.”

Share this Page